Redsense Medical AB (REDS.ST)
- Previous Close
5.82 - Open
5.84 - Bid 5.82 x --
- Ask 6.50 x --
- Day's Range
5.84 - 5.84 - 52 Week Range
4.75 - 8.48 - Volume
502 - Avg. Volume
12,048 - Market Cap (intraday)
96.038M - Beta (5Y Monthly) 0.51
- PE Ratio (TTM)
292.00 - EPS (TTM)
0.02 - Earnings Date May 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe, Canada, and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an optic fiber and an absorbent sponge-like material. It also provides Redsense Clamp, an accessory to the alarm unit enabling automatic stop of the flow in the blood line in case of an incident, regardless of the type of dialysis machine. It serves the requirements of healthcare providers in the dialysis sector. Redsense Medical AB (publ) was founded in 2000 and is based in Halmstad, Sweden.
redsensemedical.comRecent News: REDS.ST
View MorePerformance Overview: REDS.ST
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: REDS.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: REDS.ST
View MoreValuation Measures
Market Cap
95.71M
Enterprise Value
80.35M
Trailing P/E
291.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.53
Price/Book (mrq)
2.42
Enterprise Value/Revenue
2.85
Enterprise Value/EBITDA
180.98
Financial Highlights
Profitability and Income Statement
Profit Margin
1.19%
Return on Assets (ttm)
0.38%
Return on Equity (ttm)
1.09%
Revenue (ttm)
28.77M
Net Income Avi to Common (ttm)
342k
Diluted EPS (ttm)
0.02
Balance Sheet and Cash Flow
Total Cash (mrq)
15.36M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-3.18M